| Product Code: ETC6685659 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Cape Verde Pharmacogenetic Testing Market Overview |
3.1 Cape Verde Country Macro Economic Indicators |
3.2 Cape Verde Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Cape Verde Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 Cape Verde Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 Cape Verde Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Cape Verde Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 Cape Verde Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Cape Verde Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 Cape Verde Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 Cape Verde Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Cape Verde Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Cape Verde Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about personalized medicine and the benefits of pharmacogenetic testing |
4.2.2 Growing demand for precision medicine and targeted treatments |
4.2.3 Government initiatives to promote healthcare advancements and genetic testing |
4.3 Market Restraints |
4.3.1 Limited access to advanced healthcare facilities in remote areas of Cape Verde |
4.3.2 Lack of skilled professionals to conduct and interpret pharmacogenetic tests |
4.3.3 High costs associated with pharmacogenetic testing and personalized medicine |
5 Cape Verde Pharmacogenetic Testing Market Trends |
6 Cape Verde Pharmacogenetic Testing Market, By Types |
6.1 Cape Verde Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Cape Verde Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Cape Verde Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Cape Verde Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Cape Verde Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 Cape Verde Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 Cape Verde Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 Cape Verde Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 Cape Verde Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 Cape Verde Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 Cape Verde Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 Cape Verde Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 Cape Verde Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 Cape Verde Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Cape Verde Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 Cape Verde Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 Cape Verde Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 Cape Verde Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 Cape Verde Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 Cape Verde Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 Cape Verde Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 Cape Verde Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 Cape Verde Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 Cape Verde Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Cape Verde Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 Cape Verde Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 Cape Verde Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 Cape Verde Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 Cape Verde Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 Cape Verde Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 Cape Verde Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Cape Verde Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Cape Verde Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Cape Verde Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 Cape Verde Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 Cape Verde Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 Cape Verde Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Cape Verde Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 Cape Verde Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 Cape Verde Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Cape Verde Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Cape Verde Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 Cape Verde Pharmacogenetic Testing Market Export to Major Countries |
7.2 Cape Verde Pharmacogenetic Testing Market Imports from Major Countries |
8 Cape Verde Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Rate of adoption of pharmacogenetic testing by healthcare providers in Cape Verde |
8.2 Number of research studies and publications on pharmacogenetics specific to the Cape Verde population |
8.3 Percentage of healthcare budget allocated towards genetic testing and personalized medicine research |
9 Cape Verde Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 Cape Verde Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Cape Verde Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 Cape Verde Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Cape Verde Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 Cape Verde Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 Cape Verde Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Cape Verde Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Cape Verde Pharmacogenetic Testing Market - Competitive Landscape |
10.1 Cape Verde Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Cape Verde Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here